ArticleInternational journal of molecular sciences2025

Preclinical Efficacy of the Estrogen Receptor Degrader Fulvestrant in Combination with RAF/MEK Clamp Avutometinib and FAK Inhibitor in a Low-Grade Serous Ovarian Cancer Animal Model with Acquired Resistance to Chemotherapy and Aromatase Inhibitor.

Cem Demirkiran et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.